Spinal Muscular Atrophy Diagnosed by Newborn Screening
<div><p>A panel of experts representing academic centers, family foundations and pharmaceutical industry came together to formulate a treatment algorithm for infants diagnosed via newborn screening (NBS) with Spinal muscular atrophy (SMA).</p></div>
Saved in:
Main Authors: | Matias Lopez-Chacon (Author), Amber N Buehner (Author), Vamshi K Rao (Author) |
---|---|
Format: | Book |
Published: |
Pediatric Neurology Briefs Publishers,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Newborn Screening for Spinal Muscular Atrophy: Variations in Practice and Early Management of Infants with Spinal Muscular Atrophy in the United States
by: Craig M. Zaidman, et al.
Published: (2024) -
Systematic Review of Newborn Screening Programmes for Spinal Muscular Atrophy
by: Katy Cooper, et al.
Published: (2024) -
Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan
by: Tomokazu Kimizu, et al.
Published: (2021) -
CDC's Laboratory Activities to Support Newborn Screening for Spinal Muscular Atrophy
by: Francis K. Lee, et al.
Published: (2024) -
Massachusetts' Findings from Statewide Newborn Screening for Spinal Muscular Atrophy
by: Jaime E. Hale, et al.
Published: (2021)